Medindia

X

Sun Pharma Receives Warning Letter from USFDA Relating to Its Gujarat Plant

by Dr. Trupti Shirole on  December 23, 2015 at 12:01 PM Drug News   - G J E 4
Drug major Sun Pharmacuetical Industries Ltd has received a warning letter from US Food and Drug Administration (USFDA) relating to its facility in Halol in Gujarat.

The letter was a result of the inspection done by the USFDA at Halol plant in September 2014.
 Sun Pharma Receives Warning Letter from USFDA Relating to Its Gujarat Plant
Sun Pharma Receives Warning Letter from USFDA Relating to Its Gujarat Plant
Advertisement

In a statement Sun Pharma said, "We would respond to the warning letter with a detailed plan within the stipulated timeframe."

‘Post the September 2014 inspection, the USFDA has withheld future product approvals from Sun Pharma's Halol facility in Gujarat.’
Advertisement
Dilip Shanghvi, managing director, said, "While our team is working hard to ensure that the commitments made to the USFDA in September 2014 are fully completed, we will continue to cooperate with the USFDA and undertake any additional steps necessary to ensure that the US agency is completely satisfied with our remediation of the Halol facility."

Post the September 2014 inspection, the USFDA has withheld future product approvals from the Halol facility.

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: